Long-term treatment results for nasopharyngeal carcinoma: The Sahlgrenska University Hospital experience

References

• Swedish Cancer Registry. Cancer incidence in Sweden 2000–2004. Stockholm: Swedish National Board of Health and Welfare (Socialstyrelsen), Centre for Epidemiology; 2001–2005.
   Google Scholar
• Yeh SA, Tang Y, Lui CC, Huang YJ, Huang EY. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 2005; 62: 672–9
   PubMed Web of Science ®Google Scholar
• Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 1998; 16: 1310–7
   PubMed Web of Science ®Google Scholar
• Chua DT, Sham JS, Choy D, Kwong DL, Au GK, Kwong PW, et al. Patterns of failure after induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma: The Queen Mary Hospital experience. Int J Radiat Oncol Biol Phys 2001; 49: 1219–28
   PubMedGoogle Scholar
• Langendijk JA, Leemans CR, Buter J, Berkhof J, Slotman BJ. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: A meta-analysis of the published literature. J Clin Oncol 2004; 22: 4604–12
   PubMed Web of Science ®Google Scholar
• Kwong D, Sham J, Choy D. The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: An analysis of 1301 patients. Int J Radiat Oncol Biol Phys 1994; 30: 1029–36
   PubMedGoogle Scholar
• Jen YM, Lin YS, Su WF, Hsu WL, Hwang JM, Chao HL, et al. Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: Does heavier dosing result in a happier ending?. Int J Radiat Oncol Biol Phys 2002; 54: 14–22
   PubMedGoogle Scholar
• Levendag PC, Lagerwaard FJ, Noever I, dePan C, vanNimwegen A, Wijers O, et al. Role of endocavitary brachytherapy with or without chemotherapy in cancer of the nasopharynx. Int J Radiat Oncol Biol Phys 2002; 52: 755–68
   PubMedGoogle Scholar
• Fleming ID, Cooper JS, Henson DE. American Joint Committee on Cancer manual for staging of cancer. 5th ed. Philadelphia: Lippincott-Raven; 1997.
   Google Scholar
• International histological classification of tumours. Histological typing of upper respiratory tract tumors. Geneva: World Health Organization; 1978. Report No.: 19.
   Google Scholar
• Joiner MC, Bentzen SM. Time-dose relationships: The linear-quadratic approach. Basic clinical radiobiology3rd ed, Go Steel. Arnold, London 2002; 120–33
   Google Scholar
• NCI. Common Terminology Criteria For Adverse Events, Version 3.0 (CTCAE v3.0); 2003 12/12/2003.
   Google Scholar
• LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 1995;31:1049–91.
   PubMedGoogle Scholar
• Lin JC, Chen KY, Jan JS, Hsu CY. Partially hyperfractionated accelerated radiotherapy and concurrent chemotherapy for advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1996; 36: 1127–36
   PubMedGoogle Scholar
• Teo PM, Leung SF, Chan AT, Leung TW, Choi PH, Kwan WH, et al. Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Radiat Oncol Biol Phys 2000; 48: 1311–22
   PubMed Web of Science ®Google Scholar
• Rischin D, Corry J, Smith J, Stewart J, Hughes P L P. Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation. J Clin Oncol 2002; 20: 1845–52
   PubMed Web of Science ®Google Scholar
• Palazzi M, Guzzo M, Tomatis S, Cerrotta A, Potepan P, Quattrone P, et al. Improved outcome of nasopharyngeal carcinoma treated with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2004; 60: 1451–8
   PubMedGoogle Scholar
• Chua DT, Sham JS, Choy D, Lorvidhaya V, Sumitsawan Y, Thongprasert S, et al. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group. Cancer 1998; 83: 2270–83
   PubMed Web of Science ®Google Scholar
• Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT, et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 2006; 64: 47–56
   PubMed Web of Science ®Google Scholar
• Wang CC. Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Techniques and results. Cancer 1989; 63: 2461–7
   PubMed Web of Science ®Google Scholar
• Taheri-Kadkhoda Z, Pettersson N, Bäck A, Björk-Eriksson T, Mercke C, Johansson K-A. 3DCRT combined with brachy boost contra simultaneous integrated multi-target IMRT for nasopharyngeal carcinoma: Comparison of dose distribution and tumour effect. In: East-West Symposium on Nasopharyngeal Carcinoma. Toronto, Canada; 2005.
   Google Scholar
• Honore HB, Bentzen SM, Moller K, Grau C. Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: Individualized risk estimation. Radiother Oncol 2002; 65: 9–16
   PubMed Web of Science ®Google Scholar
• Kam MK, Chau RM, Suen J, Choi PH, Teo PM. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: Dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 2003; 56: 145–57
   PubMedGoogle Scholar
• Sultanem K, Shu HK, Xia P, Akazawa C, Quivey JM, Verhey LJ, et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: The University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 2000; 48: 711–22
   PubMed Web of Science ®Google Scholar
• Bjork-Eriksson T, Glimelius B. The potential of proton beam therapy in paediatric cancer. Acta Oncol 2005; 44: 871–5
   PubMed Web of Science ®Google Scholar
• Ask A, Bjork-Eriksson T, Zackrisson B, Blomquist E, Glimelius B. The potential of proton beam radiation therapy in head and neck cancer. Acta Oncol 2005; 44: 876–80
   PubMed Web of Science ®Google Scholar